BLAINJECTIONSOLUTIONPriority Review
Approved
Oct 2020
Lifecycle
Peak
Competitive Pressure
30/100
Clinical Trials
1
Mechanism of Action
IgG1κ monoclonal antibodies (atoltivimab, maftivimab, and odesivimab) that inhibit Orthoebolavirus zairense [ see ].
Clinical Trials (1)
Impact of Delay Between Administration of Inmazeb Administration and Vaccination by Ervebo on Vaccine Immune Response on Healthy Volunteers
Started Jan 2027
132 enrolled
Ebola Virus Disease